✓Medically Reviewed by Dr. Şekip Altunkan on Nov 21, 2026.
Image generated with artificial intelligence · VitalsDaily
Key Takeaway
Three pivotal themes took center stage at the American Heart Association (AHA) Scientific Sessions: novel therapeutics targeting lipoprotein(a)—a genetically determined atherogenic lipid particle; the emerging role of GLP-1 receptor agonists in managing obstructive sleep apnea; and whether older adults can safely discontinue long-standing statin therapy. Rather than dictating immediate shifts in clinical guidelines, these developments illuminate the evolving horizon of cardiovascular medicine, with each frontier still awaiting confirmation from definitive phase 3 clinical outcome trials.
The Heart Attack Nobody Expected
Imagine a 52-year-old woman who runs regularly, maintains pristine cholesterol panels, exhibits normal blood pressure, and has no history of diabetes—yet suffers a sudden myocardial infarction. Her father had also suffered a heart attack at 55. When her cardiologist finally orders a test rarely included in standard preventive workups—lipoprotein(a)—the result comes back at 210 nmol/L, far above the threshold of clinical concern. For decades, clinicians faced with this exact scenario could offer little beyond confirming that the risk was hereditary and that no approved pharmacotherapy existed to lower it.
This patient archetype, alongside two equally vexing clinical dilemmas, framed an interview with Dr. Brahmajee Nallamothu, co-chair of this year’s AHA Scientific Sessions. Published as a Medical News feature in JAMA, the discussion explored targeted Lp(a) reduction, the integration of GLP-1 receptor agonists into sleep medicine, and the nuanced calculus…
ŞA
Medically reviewed by
Dr. Şekip Altunkan
Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."